Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters [PDF]
Frontiers in ImmunologyBackgroundCharacterizing the antibody epitope profiles of messenger RNA (mRNA)-based vaccines against SARS-CoV-2 can aid in elucidating the mechanisms underlying the antibody-mediated immune responses elicited by these vaccines.MethodsThis study ...
Bethany Girard +17 more
doaj +5 more sources
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers [PDF]
International Journal of Infectious Diseases, 2022 Objectives: There are limited comparative immunologic durability data post COVID-19 vaccinations. Methods: Approximately 8.4 months after primary COVID-19 vaccination, 647 healthcare workers completed surveys about COVID-19 vaccinations/infections and ...
Wendy M. Brunner +13 more
doaj +2 more sources
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study. [PDF]
PLoS Medicine, 2022 BackgroundMyocarditis and pericarditis following the Coronavirus Disease 2019 (COVID-19) mRNA vaccines administration have been reported, but their frequency is still uncertain in the younger population.
Marco Massari +26 more
doaj +3 more sources
Breakhthrough Infection Pasca Pemberian Booster mRNA Heterolog pada Tenaga Kesehatan di RSUD Arifin Achmad [PDF]
Majalah Kedokteran Andalas, 2023 Tujuan: Mengetahui prevalensi dan karakteristik responden breakthrough infection pada tenaga kesehatan di RSUD Arifin Achmad Provinsi Riau dalam 14 hari – 6 bulan pasca vaksinasi booster mRNA-1273. Metode: Metode penelitian cross sectional yang dilakukan
Dina Br Nababan +4 more
doaj +3 more sources
mRNA-1273 is placenta-permeable and immunogenic in the fetus [PDF]
Molecular Therapy: Nucleic AcidsCOVID-19 mRNA vaccines are generally recognized as safe for gestational administration. However, their transplacental pharmacokinetics remain obscure. In this study, mRNA-1273 intramuscularly given to pregnant mice rapidly circulated in maternal blood ...
Jeng-Chang Chen +7 more
doaj +2 more sources
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines [PDF]
Frontiers in Cardiovascular Medicine, 2023 ImportanceThere is a high level of public and professional interest related to potential safety issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events were reported in phase 3 randomized controlled trials of their safety and ...
Manan Pareek +6 more
doaj +4 more sources
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination [PDF]
Vaccines, 2022 The objective of this study was to assess the local and systemic adverse reactions after the administration of a COVID-19 mRNA-1273 booster between December 2021 and February 2022 by comparing the type of mRNA vaccine used as primary series (mRNA-1273 or
Oleguer Parés-Badell +12 more
doaj +5 more sources
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results [PDF]
Frontiers in Immunology, 2021 Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days ...
Andrea Lombardi +13 more
doaj +3 more sources
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers [PDF]
BMC Infectious DiseasesBackground Data on the dynamics and persistence of humoral immunity against SARS-CoV-2 after primary vaccination with two-dose inactivated vaccine (CoronaVac) are limited.
Suwarti Suwarti +23 more
doaj +3 more sources